ID
77
Description
Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) Inclusion criteria: - cytological confirmation of AML - relapsed disease following first CR of 1 month(30days) to 24 months(730days). The time from first relapse to study entry (start of first course of induction chemotherapy) must be no longer than 30days - confirmation of FLT-3 activating mutation positive status after point of initial relapse - aged 18 years or older - written informed consent - ability to understand and comply with study restrictions - no comorbid conditions that would limit life expectancy to less than 3 months - ECOG Performance Score of 0, 1,or 2 - women must be neither pregnant nor lactating, and either of non-childbearing potential or using adequate contraception with a negative pregnancy test at study entry Exclusion criteria - bilirubin more than 2x ULN - ALT/AST more than 3x ULN - serum creatinine more than 1.5 mg/dL - resting ejection fraction of left ventricle l less than 45% (applies only to patients scheduled to receive mitoxantrone, etoposide, and cytarabine (MEC) - untreated or progressive infection - any physical or psychiatric cdtn that may compromise participation in the study - known CNS involvement with AML - any previous treatment with a FLT-3 inhibitor - requires current treatment for HIV with protease inhibitors - active GI ulceration or bleeding - use of an investigational drug that is not expected to be cleared by the start of CEP-701 treatment
Mots-clés
Versions (3)
- 18/11/2011 18/11/2011 -
- 26/03/2014 26/03/2014 - Martin Dugas
- 17/09/2021 17/09/2021 -
Téléchargé le
18 novembre 2011
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility NCT00079482 AML
Eligibility
- StudyEvent: Eligibility
Description
Ausschlusskriterien
Description
Bilirubin
Type de données
boolean
Description
ALT / AST
Type de données
boolean
Description
Serum creatinine
Type de données
boolean
Description
Ejection fraction
Type de données
boolean
Description
Infection
Type de données
boolean
Description
Major physical or psychiatric condition
Type de données
boolean
Description
CNS involvement
Type de données
boolean
Description
Previous FLT-3 inhibitor
Type de données
boolean
Description
HIV treatment
Type de données
boolean
Description
Gastrointestinal ulceration or bleeding
Type de données
boolean
Description
Other investigational drug
Type de données
boolean
Description
Medizinische Konzepte
Description
Diagnosis
Type de données
string
Alias
- UMLS CUI
- C0011900
- SNOMED CT 2010_0731
- 439401001
Description
AML
Type de données
string
Alias
- UMLS CUI
- C0023467
- SNOMED CT 2010_0731
- 91861009
- MedDRA 13.1
- 10000884
Description
Relapse
Type de données
string
Alias
- UMLS CUI
- C0035020
- SNOMED CT 2010_0731
- 263855007
- MedDRA 13.1
- 10000884
Description
FLT3 gene mutation analysis
Type de données
string
Alias
- UMLS CUI
- C1953284
Description
Age
Type de données
string
Alias
- UMLS CUI
- C0001779
- SNOMED CT 2010_0731
- 102518004
Description
Compliance
Type de données
string
Alias
- UMLS CUI
- C1321605
- SNOMED CT 2010_0731
- 405078008
Description
Life expectancy
Type de données
string
Alias
- UMLS CUI
- C0023671
- LOINC Version 232
- LP75025-4
Description
ECOG performance status
Type de données
string
Alias
- SNOMED CT 2010_0731
- 423740007
Description
pregnant
Type de données
string
Alias
- UMLS CUI
- C0549206
- MedDRA 13.1
- 10036586
Description
Lactation
Type de données
string
Alias
- UMLS CUI
- C0006147
- MedDRA 13.1
- 10006247
Description
Bilirubin
Type de données
string
Alias
- SNOMED CT 2010_0731
- 79706000
- UMLS CUI
- C0011221
- MedDRA Version 13.1
- 10004683
- LOINC
- 1975-2
Description
AST
Type de données
string
Alias
- SNOMED CT 2010_0731
- 26091008
- UMLS CUI
- C0004002
- MedDRA Version 13.1
- 10003543
- LOINC
- 1920-8
Description
ALT
Type de données
string
Alias
- SNOMED CT 2010_0731
- 56935002
- UMLS CUI
- C0001899
- MedDRA Version 13.1
- 10001844
- LOINC
- 1742-6
Description
Creatinine
Type de données
string
Alias
- UMLS CUI
- C0010294
- SNOMED CT 2010_0731
- 15373003
- LOINC
- 38483-4
- MedDRA 13.1
- 10011358
Description
Cardiac ejection fraction
Type de données
string
Alias
- UMLS CUI
- C0232174
- SNOMED CT 2010_0731
- 70822001
Description
Infection
Type de données
string
Alias
- UMLS CUI
- C0021311
- SNOMED CT 2010_0731
- 257551009
- MedDRA Version 13.1
- 10021789
Description
CNS involvement
Type de données
string
Alias
- UMLS CUI
- C0449389
- SNOMED CT 2010_0731
- 260766009
Description
Pharmaceutical Preparations
Type de données
string
Alias
- UMLS CUI
- C0013227
Description
HIV negative
Type de données
string
Alias
- UMLS CUI
- C0481430
- SNOMED CT 2010_0731
- 143223008
Description
Gastrointestinal ulcer
Type de données
string
Alias
- UMLS CUI
- C0237938
- SNOMED CT 2010_0731
- 40845000
- MedDRA Version 13.1
- 10061459
Description
Gastrointestinal hemorrhage
Type de données
string
Alias
- UMLS CUI
- C0017181
- SNOMED CT 2010_0731
- 74474003
- MedDRA Version 13.1
- 10017936
Description
Enrollment
Type de données
string
Alias
- UMLS CUI
- C1516879
Similar models
Eligibility
- StudyEvent: Eligibility
439401001 (SNOMED CT 2010_0731)
91861009 (SNOMED CT 2010_0731)
10000884 (MedDRA 13.1)
263855007 (SNOMED CT 2010_0731)
10000884 (MedDRA 13.1)
102518004 (SNOMED CT 2010_0731)
405078008 (SNOMED CT 2010_0731)
10036586 (MedDRA 13.1)
10006247 (MedDRA 13.1)
70822001 (SNOMED CT 2010_0731)
257551009 (SNOMED CT 2010_0731)
10021789 (MedDRA Version 13.1)
260766009 (SNOMED CT 2010_0731)
143223008 (SNOMED CT 2010_0731)
40845000 (SNOMED CT 2010_0731)
10061459 (MedDRA Version 13.1)
74474003 (SNOMED CT 2010_0731)
10017936 (MedDRA Version 13.1)